https://xvivo.considbrs.se/pressreleases/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012/ 2012-10-04T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012/ 2012-10-04T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/sammanfattning-januari-september-2012/ 2012-11-01T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/summary-january-september-2012/ 2012-11-01T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada/ 2012-11-08T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-erhaller-forsaljningsgodkannande-for-steen-solution-i-kanada/ 2012-11-08T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion/ 2012-11-21T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/new-sales-and-marketing-director-at-xvivo-perfusion/ 2012-11-21T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/ytterligare-stamning-mot-vitrolifes-amerikanska-dotterbolag-rorande-perfadex/ 2013-02-07T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/further-lawsuits-filed-against-vitrolifes-american-subsidiary-regarding-perfadex/ 2013-02-07T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telekonferens-avseende-bokslutskommunike-2012/ 2013-02-15T11:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-the-report-on-operations-2012/ 2013-02-15T11:30:00+00:00 https://xvivo.considbrs.se/pressreleases/report-on-operations-2012/ 2013-02-19T15:30:00+00:00 https://xvivo.considbrs.se/pressreleases/bokslutskommunike-2012/ 2013-02-19T15:30:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-general-meeting-of-xvivo-perfusion-ab-publ-7/ 2013-04-08T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-arsstamma-i-xvivo-perfusion-ab-publ-11/ 2013-04-08T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-interim-report-6/ 2013-04-11T09:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telekonferens-avseende-delarsrapport-3/ 2013-04-11T09:30:00+00:00 https://xvivo.considbrs.se/pressreleases/klarlaggande-xvivo-perfusions-rattigheter-till-professor-stig-steens-medier-for-preservation-och-evaluering-av-organ/ 2013-04-12T09:30:00+00:00 https://xvivo.considbrs.se/pressreleases/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs/ 2013-04-12T09:45:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-report-2012/ 2013-04-15T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/arsredovisning-2012/ 2013-04-15T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-mars-2013/ 2013-04-19T11:00:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-march-2013/ 2013-04-19T11:00:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-arsstamma-i-xvivo-perfusion-ab-publ-11/ 2013-05-08T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/report-from-annual-general-meeting-of-xvivo-perfusion-ab-publ-8/ 2013-05-08T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telekonferens-avseende-delarsrapport-2/ 2013-07-01T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-interim-report-5/ 2013-07-01T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/share-warrant-program-fully-subscribed-4/ 2013-07-04T14:30:00+00:00 https://xvivo.considbrs.se/pressreleases/teckningsoptionsprogrammet-fulltecknat-4/ 2013-07-04T14:30:00+00:00 https://xvivo.considbrs.se/pressreleases/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution/ 2013-07-09T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/all-patients-included-in-the-novel-trial-in-the-usa-with-steen-solution/ 2013-07-09T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-juni-2013/ 2013-07-11T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-june-2013/ 2013-07-11T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/novel-trial-recruitment-of-patients-complete-fda-has-decided-that-an-expert-panel-meeting-will-be-held-q1-of-2014/ 2013-09-20T14:55:00+00:00 https://xvivo.considbrs.se/pressreleases/steen-solution-studien-i-usa-fardigrekryterad-fda-har-bestamt-att-ett-expertmote-ska-hallas-i-forsta-kvartalet-2014/ 2013-09-20T14:55:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-files-lawsuit-against-vivoline/ 2013-10-11T09:50:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-stammer-vivoline/ 2013-10-11T09:50:00+00:00 https://xvivo.considbrs.se/pressreleases/valberedning-i-xvivo-perfusion-ab-publ-11/ 2013-10-16T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/election-committee-of-xvivo-perfusion-ab-publ-4/ 2013-10-16T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-lanserar-xps-systemet-i-europa/ 2013-10-18T08:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-launches-the-xps-system-in-europe/ 2013-10-18T08:30:00+00:00 https://xvivo.considbrs.se/pressreleases/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion/ 2013-10-25T08:30:00+00:00 https://xvivo.considbrs.se/pressreleases/dr-joel-cooper-ny-medical-advisor-for-xvivo-perfusion/ 2013-10-25T08:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-interim-report-4/ 2013-10-29T09:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telekonferens-avseende-delarsrapport/ 2013-10-29T09:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-utokar-novel-studien-i-usa/ 2013-11-06T10:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-expands-the-novel-study-in-the-usa/ 2013-11-06T10:00:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-september-2013/ 2013-11-07T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-september-2013/ 2013-11-07T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/unikt-samarbete-mellan-opo-och-transplantationsklinik-inledd-i-xvivos-amerikanska-studie/ 2013-12-19T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/unique-collaboration-between-opo-and-transplant-center-initiated-in-xvivos-us-clinical-trial/ 2013-12-19T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-bokslutskommunike-2013/ 2014-01-28T13:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-report-on-operations-2013/ 2014-01-28T13:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-expands-the-us-study-with-another-leading-transplant-center/ 2014-01-29T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik/ 2014-01-29T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/report-on-operations-2013/ 2014-02-07T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/bokslutskommunike-2013/ 2014-02-07T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/progress-made-in-the-novel-study-in-the-usa/ 2014-03-14T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/framsteg-i-novel-studien-i-usa/ 2014-03-14T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/fdas-expertpanelen-rostade-enhalligt-for-att-xps-med-steen-solution-uppfyller-kraven-for-hde/ 2014-03-21T07:00:00+00:00 https://xvivo.considbrs.se/pressreleases/the-fda-advisory-panel-voted-unanimously-that-xps-with-steen-solution-meets-the-requirements-for-hde/ 2014-03-21T07:00:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-general-meeting-of-xvivo-perfusion-ab-publ-6/ 2014-03-28T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-arsstamma-i-xvivo-perfusion-ab-publ-10/ 2014-03-28T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-systemet-har-erhallit-ce-marke/ 2014-03-31T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-has-received-ce-mark/ 2014-03-31T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/arsredovisning-2013/ 2014-04-07T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-report-2013/ 2014-04-07T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-interim-report-3/ 2014-04-14T13:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-30/ 2014-04-14T13:30:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-mars-2014/ 2014-04-23T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-march-2014/ 2014-04-23T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-arsstamma-i-xvivo-perfusion-ab-publ-10/ 2014-04-30T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/report-from-annual-general-meeting-of-xvivo-perfusion-ab-publ-7/ 2014-04-30T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-avser-att-genomfora-en-riktad-emission-av-aktier/ 2014-06-25T15:31:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-intends-to-undertake-a-private-placement-of-shares/ 2014-06-25T15:31:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-has-completed-a-private-placement-of-shares/ 2014-06-26T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-genomfor-en-riktad-nyemission/ 2014-06-26T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/teckningsoptionsprogrammet-fulltecknat-3/ 2014-07-07T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/share-warrant-program-fully-subscribed-3/ 2014-07-07T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-29/ 2014-08-07T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-interim-report-2/ 2014-08-07T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/continued-strong-sales-growth-and-sek-73-million-private-placement/ 2014-08-13T06:29:00+00:00 https://xvivo.considbrs.se/pressreleases/fortsatt-stark-forsaljningstillvaxt-samt-riktad-nyemission-om-73-msek/ 2014-08-13T06:29:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-har-erhallit-marknadsgodkannande-for-steen-solution-och-xps-av-fda/ 2014-08-13T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-has-received-market-approval-from-the-fda-for-steen-solution-and-xps/ 2014-08-13T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-far-horizon-2020-finansiering/ 2014-09-19T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-receives-horizon-2020-funding/ 2014-09-19T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/installation-av-den-forsta-xpsen-i-asien/ 2014-09-30T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/installation-of-the-first-xps-in-asia/ 2014-09-30T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/election-committee-of-xvivo-perfusion-ab-publ-3/ 2014-10-16T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/valberedning-i-xvivo-perfusion-ab-publ-10/ 2014-10-16T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-28/ 2014-10-17T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-interim-report/ 2014-10-17T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/fortsatt-stark-forsaljningstillvaxt-samt-fda-godkannande-for-xps-och-steen-solution/ 2014-10-24T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/continued-strong-sales-growth-and-fda-approval-for-xps-and-steen-solution/ 2014-10-24T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-obtains-financing-from-vinnova-for-cancer-research/ 2014-11-20T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-far-vinnova-finansiering-for-cancerforskning/ 2014-11-20T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/utfall-i-skiljedom-angaende-xvivo-perfusions-rattigheter-till-vivoline-patent/ 2014-12-18T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/decision-of-the-arbitration-board-regarding-xvivo-perfusions-rights-to-the-vivoline-patents/ 2014-12-18T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-bokslutskommunike-2014/ 2015-01-27T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-report-on-operations-2014/ 2015-01-27T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-breaks-new-ground-in-germany-and-texas/ 2015-02-04T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-bryter-ny-mark-i-tyskland-och-texas/ 2015-02-04T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/strong-growth-and-doubled-ebitda-exklusive-one-time-expenses/ 2015-02-05T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/hog-tillvaxt-och-dubblerad-ebitda-exklusive-engangskostnader/ 2015-02-05T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/settlement-between-xvivo-and-vivoline/ 2015-02-09T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/uppgorelse-mellan-xvivo-och-vivoline/ 2015-02-09T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-approved-in-australia/ 2015-02-19T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-godkand-i-australien/ 2015-02-19T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/two-xps-to-florida/ 2015-03-19T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/tva-xps-till-florida/ 2015-03-19T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-har-erhallit-metodpatent-for-steen-solution-i-usa/ 2015-03-20T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-granted-method-patent-for-steen-solution-in-usa/ 2015-03-20T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-arsstamma-i-xvivo-perfusion-ab-publ-9/ 2015-03-24T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-general-meeting-of-xvivo-perfusion-ab-publ-5/ 2015-03-24T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/first-xps-to-southern-europe-and-continued-success-in-the-us/ 2015-03-27T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/forsta-xps-till-sydeuropa-och-fortsatta-framgangar-i-usa/ 2015-03-27T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/arsredovisning-2014/ 2015-03-31T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-report-2014/ 2015-03-31T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-27/ 2015-04-14T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-27/ 2015-04-14T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-march-2015/ 2015-04-22T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-mars-2015/ 2015-04-22T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-arsstamma-i-xvivo-perfusion-ab-publ-9/ 2015-04-23T15:20:00+00:00 https://xvivo.considbrs.se/pressreleases/report-from-annual-general-meeting-of-xvivo-perfusion-ab-publ-6/ 2015-04-23T15:23:00+00:00 https://xvivo.considbrs.se/pressreleases/teckningsoptionsprogrammet-fulltecknat-2/ 2015-07-02T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/share-warrant-program-fully-subscribed-2/ 2015-07-02T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-installerar-ytterligare-tva-xps-i-usa/ 2015-08-03T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-adds-two-more-xps-installations-in-the-u-s/ 2015-08-03T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-26/ 2015-08-04T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-26/ 2015-08-04T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/forsta-levertransplantationen-med-steen-solution/ 2015-08-06T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/first-liver-transplant-with-steen-solution-performed/ 2015-08-06T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-juni-2015/ 2015-08-13T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-june-2015/ 2015-08-13T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/election-committee-of-xvivo-perfusion-ab-publ-2/ 2015-09-22T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/valberedning-i-xvivo-perfusion-ab-publ-9/ 2015-09-22T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-till-varldens-nast-storsta-lungtransplantationsklinik/ 2015-10-08T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-at-the-worlds-second-largest-lung-transplant-clinic/ 2015-10-08T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-25/ 2015-10-19T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-25/ 2015-10-19T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/forsta-levertransplantationen-med-steen-solution-utford-under-kvartalet/ 2015-10-23T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/first-liver-transplant-with-steen-solution-performed-during-the-quarter/ 2015-10-23T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/steen-solution-approved-in-china/ 2015-11-20T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/steen-solution-godkant-i-kina/ 2015-11-20T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-godkand-i-kanada/ 2015-11-26T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-approved-in-canada/ 2015-11-26T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-forstarker-ledningsgruppen/ 2015-12-08T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-strengthens-management-team/ 2015-12-08T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-to-germany/ 2015-12-23T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-till-tyskland/ 2015-12-23T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/primecc-has-been-granted-ce-mark/ 2016-01-07T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/primecc-har-erhallit-ce-marke/ 2016-01-07T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-report-on-operations-2015/ 2016-01-28T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-bokslutskommunike-2015/ 2016-01-28T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-till-schweiz/ 2016-01-29T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-to-switzerland/ 2016-01-29T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/report-on-operations-2015/ 2016-02-04T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/bokslutskommunike-2015/ 2016-02-04T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-first-north-premier/ 2016-02-05T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-admitted-to-trading-on-nasdaq-first-north-premier/ 2016-02-05T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/perfadex-and-steen-solution-approved-in-russia/ 2016-02-16T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/perfadex-och-steen-solution-godkanda-i-ryssland/ 2016-02-16T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-to-be-delivered-to-the-first-clinic-in-france/ 2016-02-24T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-levereras-till-forsta-kliniken-i-frankrike/ 2016-02-24T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-arsstamma-i-xvivo-perfusion-ab-publ-8/ 2016-03-31T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-general-meeting-of-xvivo-perfusion-ab-publ-4/ 2016-03-31T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/arsredovisning-2015/ 2016-04-11T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-report-2015/ 2016-04-11T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-contract-signed-with-leading-hospital-in-boston/ 2016-04-15T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-kontrakt-med-klinik-i-boston/ 2016-04-15T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-announces-a-recommended-public-offer-to-the-holders-of-shares-and-warrants-of-series-2015-2016-in-vivoline-medical/ 2016-04-18T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-lamnar-ett-rekommenderat-offentligt-erbjudande-till-agare-av-aktier-och-teckningsoptioner-av-serie-2015-2016-i-vivoline-medical/ 2016-04-18T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-24/ 2016-04-22T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-24/ 2016-04-22T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-delarsrapport-januari-mars-2016/ 2016-04-26T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-interim-report-january-march-2016/ 2016-04-26T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-arsstamma-i-xvivo-perfusion-ab-publ-8/ 2016-05-04T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/report-from-annual-general-meeting-of-xvivo-perfusion-ab-publ-5/ 2016-05-04T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-published-prospectus-regarding-the-public-offer-to-the-holders-of-shares-and-warrants-of-series-2015-2016-in-vivoline-medical/ 2016-05-10T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-offentliggor-prospekt-avseende-erbjudandet-till-agare-av-aktier-och-teckningsoptioner-av-serie-2015-2016-i-vivoline-medical/ 2016-05-10T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders/ 2016-05-17T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-information-angaende-erbjudandet-till-vivolines-aktieagare/ 2016-05-17T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-declares-the-public-offer-on-vivoline-medical-unconditional-announces-the-outcome-and-extends-the-acceptance-period/ 2016-06-08T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-forklarar-budet-pa-vivoline-medical-ovillkorat-offentliggor-utfallet-och-forlanger-acceptperioden/ 2016-06-08T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/forsta-patienten-i-primecc-studien-inkluderad-2/ 2016-06-15T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/first-patient-in-primecc-study-included/ 2016-06-15T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-contract-signed-with-leading-hospital-in-alabama/ 2016-06-17T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-kontrakt-med-klinik-i-alabama/ 2016-06-17T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-forlanger-acceptperioden-avseende-budet-pa-vivoline-medical/ 2016-06-21T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-extends-the-acceptance-period-for-the-public-offer-on-vivoline-medical/ 2016-06-21T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/lungcancerpatient-ges-kemoterapi-genom-in-vivo-lung-perfusion-med-steen-solution/ 2016-06-22T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/lung-cancer-patient-given-chemotherapy-through-in-vivo-lung-perfusion-with-steen-solution/ 2016-06-22T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/teckningsoptionsprogrammet-fulltecknat/ 2016-07-08T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/share-warrant-program-fully-subscribed/ 2016-07-08T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-23/ 2016-07-08T07:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-23/ 2016-07-08T07:00:00+00:00 https://xvivo.considbrs.se/pressreleases/forlangd-acceptperiod-i-xvivo-perfusions-bud-pa-vivoline-medical-avslutad/ 2016-07-15T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/extension-of-the-acceptance-period-of-xvivo-perfusions-public-offer-on-vivoline-medical-has-ended/ 2016-07-15T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-interim-report-january-june-2016/ 2016-07-15T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-juni-2016/ 2016-07-15T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/valberedning-i-xvivo-perfusion-ab-publ-8/ 2016-09-20T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/election-committee-of-xvivo-perfusion-ab-publ/ 2016-09-20T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-22/ 2016-10-21T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-22/ 2016-10-21T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/tva-ls-kontrakt-i-spanien/ 2016-10-27T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/two-ls-contract-signed-in-spain/ 2016-10-27T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-interim-report-january-september-2016/ 2016-10-27T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-september-2016/ 2016-10-27T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/clarification-of-news-about-two-ls-contract-signed-in-spain/ 2016-10-27T15:15:00+00:00 https://xvivo.considbrs.se/pressreleases/fortydligande-angaende-tva-ls-kontrakt-i-spanien/ 2016-10-27T15:15:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-har-godkants-for-notering-pa-nasdaq-stockholm-och-offentliggor-prospekt/ 2016-11-21T16:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-has-been-approved-for-listing-on-nasdaq-stockholm-and-publishes-prospectus/ 2016-11-21T16:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-bokslutskommunike-5/ 2017-02-03T09:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-report-on-operations-5/ 2017-02-03T09:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-report-on-operations-2016/ 2017-02-08T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/bokslutskommunike-2016/ 2017-02-08T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-avser-att-genomfora-en-riktad-emission-av-aktier/ 2017-03-16T17:45:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-intends-to-undertake-a-private-placement-of-shares/ 2017-03-16T17:45:00+00:00 https://xvivo.considbrs.se/pressreleases/styrelsen-for-xvivo-perfusion-beslutar-om-nyemission-om-hogst-ca-181-miljoner-kronor-riktad-till-institutionella-investerare/ 2017-03-17T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/the-board-of-directors-of-xvivo-perfusion-resolves-upon-an-up-to-approx-sek-181-million-share-issue-directed-to-institutional-investors/ 2017-03-17T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/notice-of-extraordinary-general-meeting-of-xvivo-perfusion-aktiebolag-publ/ 2017-03-17T06:35:00+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-extra-bolagsstamma-i-xvivo-perfusion-aktiebolag-publ/ 2017-03-17T06:35:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-general-meeting-of-xvivo-perfusion-ab-publ-3/ 2017-03-20T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-arsstamma-i-xvivo-perfusion-ab-publ-7/ 2017-03-20T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-report-2016/ 2017-04-04T05:00:00+00:00 https://xvivo.considbrs.se/pressreleases/arsredovisning-2016/ 2017-04-04T05:00:00+00:00 https://xvivo.considbrs.se/pressreleases/summary-from-extraordinary-general-meeting-of-xvivo-perfusion-aktiebolag-publ/ 2017-04-10T07:45:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-extra-bolagsstamma-i-xvivo-perfusion-aktiebolag-publ/ 2017-04-10T07:45:00+00:00 https://xvivo.considbrs.se/pressreleases/first-xps-sold-to-australia-and-to-the-netherlands/ 2017-04-12T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/australien-och-nederlanderna-nya-lander-med-xps/ 2017-04-12T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-21/ 2017-04-19T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-21/ 2017-04-19T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-mars-2017/ 2017-04-25T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-march-2017/ 2017-04-25T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-arsstamma-i-xvivo-perfusion-ab-publ-7/ 2017-04-26T15:15:00+00:00 https://xvivo.considbrs.se/pressreleases/report-from-annual-general-meeting-of-xvivo-perfusion-ab-publ-4/ 2017-04-26T15:17:00+00:00 https://xvivo.considbrs.se/pressreleases/change-in-number-of-shares-and-votes-in-xvivo-perfusion-6/ 2017-04-28T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-6/ 2017-04-28T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/change-in-number-of-shares-and-votes-in-xvivo-perfusion-5/ 2017-06-30T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5/ 2017-06-30T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/recruitment-completed-for-novel-study-in-the-us-on-steen-solution-and-xps/ 2017-07-06T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/novel-studien-i-usa-med-steen-solution-och-xps-fardigrekryterad/ 2017-07-06T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-20/ 2017-07-10T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-20/ 2017-07-10T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/primecc-studien-fardigrekryterad/ 2017-07-13T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/recruitment-completed-for-primecc-study/ 2017-07-13T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-june-2017/ 2017-07-14T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-juni-2017/ 2017-07-14T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusions-cfo-appointed-deputy-ceo/ 2017-07-17T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusions-cfo-utnamnd-till-vice-vd/ 2017-07-17T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/forsta-hjarttransplantationen-med-stig-steens-nya-metod-genomford-pa-manniska/ 2017-09-12T12:40:00+00:00 https://xvivo.considbrs.se/pressreleases/first-clinical-heart-transplant-performed-using-stig-steens-new-method/ 2017-09-12T12:40:00+00:00 https://xvivo.considbrs.se/pressreleases/valberedning-i-xvivo-perfusion-ab-publ-7/ 2017-09-21T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/nomination-committee-of-xvivo-perfusion-ab-publ-7/ 2017-09-21T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-19/ 2017-10-20T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-19/ 2017-10-20T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-publ-interim-report-january-september-2017/ 2017-10-27T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-publ-delarsrapport-januari-september-2017/ 2017-10-27T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/reimbursement-koder-erhallna-for-hela-evlp-processen-i-usa/ 2017-11-07T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/reimbursement-codes-obtained-for-doctors-time-during-evlp-procedure/ 2017-11-07T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/forsta-xps-installerad-i-kina/ 2017-12-01T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/first-xps-installed-in-china/ 2017-12-01T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-report-on-operations-4/ 2018-02-01T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-bokslutskommunike-4/ 2018-02-01T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/andrat-datum-for-telefonkonferens-avseende-bokslutskommunike/ 2018-02-05T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/date-changed-for-conference-call-on-report-on-operations/ 2018-02-05T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-publ-bokslutskommunike-2017/ 2018-02-09T07:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-publ-report-on-operations-2017/ 2018-02-09T07:00:00+00:00 https://xvivo.considbrs.se/pressreleases/information-fran-xvivo-perfusions-valberedning-2/ 2018-03-08T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/information-from-xvivo-perfusions-nomination-committee-2/ 2018-03-08T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/optionsprogram-till-vd-och-vice-vd-cfo/ 2018-03-22T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/option-program-for-the-ceo-and-the-deputy-ceo/ 2018-03-22T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-arsstamma-i-xvivo-perfusion-ab-publ-6/ 2018-03-22T08:30:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-general-meeting-of-xvivo-perfusion-ab-publ-2/ 2018-03-22T08:30:00+00:00 https://xvivo.considbrs.se/pressreleases/arsredovisning-2017/ 2018-04-04T10:00:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-report-2017/ 2018-04-04T10:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-18/ 2018-04-19T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-18/ 2018-04-19T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-publ-delarsrapport-januari-mars-2018/ 2018-04-26T05:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-publ-interim-report-january-march-2018/ 2018-04-26T05:00:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-arsstamma-i-xvivo-perfusion-ab-publ-6/ 2018-04-27T12:40:00+00:00 https://xvivo.considbrs.se/pressreleases/report-from-annual-general-meeting-of-xvivo-perfusion-ab-publ-3/ 2018-04-27T12:40:00+00:00 https://xvivo.considbrs.se/pressreleases/pma-ansokan-for-steen-solution-och-xps-inlamnad-till-fda/ 2018-05-11T04:00:00+00:00 https://xvivo.considbrs.se/pressreleases/pma-application-for-xps-with-steen-solution-submitted-to-the-fda/ 2018-05-11T04:00:00+00:00 https://xvivo.considbrs.se/pressreleases/positiva-fynd-i-primecc-studien/ 2018-05-14T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/positive-findings-in-the-primecc-study/ 2018-05-14T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-lanserar-perfadex-plus-en-uppgraderad-ready-to-use-version-av-perfadex/ 2018-06-05T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-launches-perfadex-plus-an-upgraded-ready-to-use-version-of-perfadex/ 2018-06-05T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/united-therapeutics-och-xvivo-perfusion-inleder-samarbete-for-att-minska-organbristen-genom-utokad-tjanst-inom-organutvardering/ 2018-06-12T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/united-therapeutics-and-xvivo-perfusion-announce-collaboration-to-reduce-organ-shortage-through-expansion-of-organ-evaluation-service/ 2018-06-12T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-changes-the-date-of-reporting-of-the-interim-report-january-june-2018-to-july-20-2018/ 2018-06-14T18:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-andrar-datum-for-rapportering-av-delarsrapport-januari-juni-2018-till-den-20-juli-2018/ 2018-06-14T18:00:00+00:00 https://xvivo.considbrs.se/pressreleases/perfadex-plus-godkant-av-fda/ 2018-06-25T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/perfadex-plus-approved-by-the-fda/ 2018-06-25T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/change-in-number-of-shares-and-votes-in-xvivo-perfusion-4/ 2018-06-29T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4/ 2018-06-29T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-17/ 2018-07-12T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-17/ 2018-07-12T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-june-2018/ 2018-07-20T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-juni-2018/ 2018-07-20T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/nomination-committee-of-xvivo-perfusion-ab-publ-6/ 2018-09-24T13:30:00+00:00 https://xvivo.considbrs.se/pressreleases/valberedning-i-xvivo-perfusion-ab-publ-6/ 2018-09-24T13:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-16/ 2018-10-17T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-16/ 2018-10-17T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-publ-delarsrapport-januari-september-2018/ 2018-10-26T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-publ-interim-report-january-september-2018/ 2018-10-26T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/professor-stig-steens-heart-preservation-technology-required-for-successful-transplantation-from-pigs-to-baboons/ 2018-12-07T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/professor-stig-steens-hjartpreservationsteknologi-en-forutsattning-for-lyckade-hjarttransplantationer-fran-gris-till-babian/ 2018-12-07T12:30:00+00:00 https://xvivo.considbrs.se/pressreleases/information-from-xvivo-perfusions-nomination-committee/ 2019-01-15T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/information-fran-xvivo-perfusions-valberedning/ 2019-01-15T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-bokslutskommunike-3/ 2019-02-04T10:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-report-on-operations-3/ 2019-02-04T10:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-publ-bokslutskommunike-2018/ 2019-02-08T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-publ-report-on-operations-2018/ 2019-02-08T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-arsstamma-i-xvivo-perfusion-ab-publ-5/ 2019-03-20T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-general-meeting-of-xvivo-perfusion-ab-publ/ 2019-03-20T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/vd-magnus-nilsson-har-kvar-lika-manga-aktier-som-innan-den-6-mars-2019/ 2019-03-25T05:00:00+00:00 https://xvivo.considbrs.se/pressreleases/ceo-magnus-nilsson-has-the-same-number-of-shares-as-before-march-6-2019/ 2019-03-25T05:00:00+00:00 https://xvivo.considbrs.se/pressreleases/rattelse-av-kallelse-till-arsstamma-i-xvivo-perfusion-ab-publ/ 2019-03-25T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/amendment-of-notice-to-attend-annual-general-meeting-of-xvivo-perfusion-ab-publ/ 2019-03-25T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-report-2018/ 2019-04-02T10:00:00+00:00 https://xvivo.considbrs.se/pressreleases/arsredovisning-2018/ 2019-04-02T10:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-15/ 2019-04-16T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-15/ 2019-04-16T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/resultat-fran-hjartpreservations-studien-presenterat-pa-ishlt/ 2019-04-23T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/results-from-the-heart-preservation-study-presented-on-ishlt/ 2019-04-23T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/strong-growth-in-warm-perfusion-and-progress-in-the-rd-portfolio/ 2019-04-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/hog-tillvaxt-for-varm-perfusion-och-framsteg-inom-fou-portfoljen/ 2019-04-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/report-from-annual-general-meeting-of-xvivo-perfusion-ab-publ-2/ 2019-04-25T14:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-arsstamma-i-xvivo-perfusion-ab-publ-5/ 2019-04-25T14:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-has-received-market-approval-pma-from-the-fda-for-steen-solution-and-xps-2/ 2019-04-26T22:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-har-erhallit-marknadsgodkannande-pma-for-steen-solution-och-xps-av-fda-2/ 2019-04-26T22:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-has-received-market-approval-pma-from-the-fda-for-steen-solution-and-xps/ 2019-04-29T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-har-erhallit-marknadsgodkannande-pma-for-steen-solution-och-xps-av-fda/ 2019-04-29T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivos-patent-for-hjartpreservations-vatska-godkanda-i-usa-och-europa/ 2019-05-02T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe/ 2019-05-02T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/forsta-xps-sald-till-kanada/ 2019-05-03T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/first-xps-sold-to-canada/ 2019-05-03T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-har-erhallit-klartecken-fran-lakemedelsverket-for-kliniska-studier-med-bolagets-nya-produkter-for-hjartpreservation/ 2019-05-15T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-has-received-approval-from-the-swedish-mpa-to-begin-clinical-studies-with-the-companys-new-products-for-heart-preservation/ 2019-05-15T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3/ 2019-05-31T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/change-in-number-of-shares-and-votes-in-xvivo-perfusion-3/ 2019-05-31T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-changes-the-date-of-reporting-of-the-report-on-operations-2019-to-january-30-2020/ 2019-06-25T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-tidigarelagger-datum-for-rapportering-av-bokslutskommunike-2019-till-den-30e-januari-2020/ 2019-06-25T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-14/ 2019-07-05T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-14/ 2019-07-05T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/historiskt-pma-godkannande-och-framsteg-i-fou-portfoljen/ 2019-07-12T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/historic-pma-approval-and-progress-in-the-rd-portfolio/ 2019-07-12T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-och-mycartis-samarbetar-inom-utveckling-av-ett-diagnostiskt-test-for-att-bedoma-kvaliteten-pa-donerade-organ-fore-transplantation/ 2019-07-17T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-and-mycartis-engage-to-develop-a-fast-diagnostic-test-to-assess-the-quality-of-donated-organs-before-transplantation/ 2019-07-17T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/perfadex-plus-has-received-patent-approval-in-europe/ 2019-08-21T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/perfadex-plus-har-erhallit-patentgodkannande-i-europa/ 2019-08-21T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/lung-bioengineering-har-kopt-en-xps-till-deras-nya-evlp-center-i-jacksonville/ 2019-08-23T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/lung-bioengineering-has-acquired-the-xps-for-use-in-its-new-jacksonville-evlp-center/ 2019-08-23T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-sold-to-china/ 2019-09-18T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-sald-till-kina/ 2019-09-18T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/valberedning-i-xvivo-perfusion-ab-publ-5/ 2019-09-24T13:30:00+00:00 https://xvivo.considbrs.se/pressreleases/nomination-committee-of-xvivo-perfusion-ab-publ-5/ 2019-09-24T13:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-13/ 2019-10-21T11:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-13/ 2019-10-21T11:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-publ-issue-of-warrants-of-series-2019-2021-fully-subscribed/ 2019-10-23T11:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-publ-teckningsoptioner-av-serie-2019-2021-fulltecknat/ 2019-10-23T11:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-opens-a-subsidiary-in-australia/ 2019-10-23T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-oppnar-ett-dotterbolag-i-australien/ 2019-10-23T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/good-growth-and-new-important-xps-clinics/ 2019-10-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/god-tillvaxt-och-viktiga-nya-xps-kliniker/ 2019-10-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/third-xps-sold-in-australia/ 2019-10-29T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/tredje-xps-till-i-australien/ 2019-10-29T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-har-fatt-breakthrough-device-designation-beviljat-fran-fda-for-xvivo-heart-preservation-system/ 2019-12-16T10:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-granted-breakthrough-device-designation-from-the-fda-for-the-xvivo-heart-preservation-system/ 2019-12-16T10:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-bokslutskommunike-2/ 2020-01-24T07:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-report-on-operations-2/ 2020-01-24T07:00:00+00:00 https://xvivo.considbrs.se/pressreleases/a-historic-year-ended-with-a-quarter-of-sales-records/ 2020-01-30T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kvartal-med-forsaljningsrekord-avslutar-ett-historiskt-ar/ 2020-01-30T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/notice-to-attend-the-annual-general-meeting-of-xvivo-perfusion-ab-publ/ 2020-02-24T22:45:00+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-arsstamma-i-xvivo-perfusion-ab-publ-4/ 2020-02-24T22:45:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-report-2019/ 2020-03-09T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/arsredovisning-2019/ 2020-03-09T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/covid-19-epidemins-paverkan-pa-xvivo-perfusion/ 2020-03-18T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/the-covid-19-effect-on-xvivo-perfusion/ 2020-03-18T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/med-anledning-av-covid-19-xvivo-perfusion-abs-arsstamma-flyttas-till-ny-adress-och-ytterligare-forsiktighetsatgarder-vidtas/ 2020-03-18T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/as-a-result-of-covid-19-the-annual-general-meeting-of-xvivo-perfusion-is-moved-to-a-new-address-and-further-precautions-are-taken/ 2020-03-18T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-advances-the-date-for-submission-of-the-january-march-2020-interim-report/ 2020-03-25T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-tidigarelagger-datum-for-avlamnande-av-delarsrapport-for-januari-mars-2020/ 2020-03-25T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/the-nomination-committee-proposes-unchanged-board-remuneration/ 2020-03-25T09:15:00+00:00 https://xvivo.considbrs.se/pressreleases/valberedningen-foreslar-oforandrade-styrelsearvoden/ 2020-03-25T09:15:00+00:00 https://xvivo.considbrs.se/pressreleases/valberedningen-foreslar-oforandrade-styrelsearvoden-justerad-version/ 2020-03-25T09:50:00+00:00 https://xvivo.considbrs.se/pressreleases/the-nomination-committee-proposes-unchanged-board-remuneration-adjusted-version/ 2020-03-25T09:50:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-sald-till-pediatrisk-transplantationsklinik-i-italien/ 2020-03-31T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-sold-to-pediatric-transplantation-clinic-in-italy/ 2020-03-31T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-arsstamma-i-xvivo-perfusion-ab-publ-4/ 2020-03-31T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/report-from-annual-general-meeting-of-xvivo-perfusion-ab-publ/ 2020-03-31T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-12/ 2020-04-02T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-12/ 2020-04-02T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-uppdaterad-lank/ 2020-04-06T09:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-link-updated/ 2020-04-06T09:30:00+00:00 https://xvivo.considbrs.se/pressreleases/strong-cash-flow-despite-the-influence-of-covid-19/ 2020-04-09T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/starkt-kassaflode-trots-paverkan-av-covid-19/ 2020-04-09T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-utnamner-ny-ip-chef-och-ny-medicinsk-chef/ 2020-04-24T13:40:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-appoints-a-new-ip-manager-and-a-new-medical-director/ 2020-04-24T13:40:00+00:00 https://xvivo.considbrs.se/pressreleases/magnus-nilsson-hands-over-the-baton-to-dag-andersson-as-president-and-ceo-of-xvivo-perfusion/ 2020-04-28T16:30:00+00:00 https://xvivo.considbrs.se/pressreleases/magnus-nilsson-lamnar-over-stafettpinnen-till-dag-andersson-som-vd-och-koncernchef-for-xvivo-perfusion/ 2020-04-28T16:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa/ 2020-05-19T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xps-sold-to-a-leading-lung-transplant-clinic-in-europe/ 2020-05-19T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/hjartpreservations-studien-fran-lund-publicerad-i-nature-communications/ 2020-06-12T14:30:00+00:00 https://xvivo.considbrs.se/pressreleases/the-study-from-lund-published-in-nature-communications/ 2020-06-12T14:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-11/ 2020-07-02T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-11/ 2020-07-02T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/i-startblocken-infor-studieuppstart-for-hjartpreservation-och-primecc/ 2020-07-10T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/in-the-starting-blocks-for-heart-preservation-and-primecc-trial/ 2020-07-10T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-starker-ledningsgruppen-med-ny-commercial-director-och-ny-rd-director/ 2020-09-04T09:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director/ 2020-09-04T09:00:00+00:00 https://xvivo.considbrs.se/pressreleases/forsta-patienten-i-primecc-studien-inkluderad/ 2020-09-09T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/first-patient-in-the-primecc-study-included/ 2020-09-09T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-extra-bolagsstamma-i-xvivo-perfusion-ab-publ/ 2020-09-11T14:15:00+00:00 https://xvivo.considbrs.se/pressreleases/notice-to-attend-the-extraordinary-general-meeting-in-xvivo-perfusion-ab-publ/ 2020-09-11T14:15:00+00:00 https://xvivo.considbrs.se/pressreleases/changes-in-xvivo-perfusions-management-team/ 2020-09-21T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/forandringar-i-xvivo-perfusions-ledningsgrupp/ 2020-09-21T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-to-acquire-the-dutch-medtech-company-organ-assist-and-finances-the-acquisition-through-a-private-placement-of-new-shares/ 2020-09-23T15:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-forvarvar-det-nederlandska-medicintekniska-foretaget-organ-assist-och-finansierar-forvarvet-genom-en-nyemission-av-aktier/ 2020-09-23T15:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-avser-att-genomfora-en-riktad-nyemission-av-aktier-2/ 2020-09-23T15:31:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-intends-to-carry-out-a-directed-issue-of-shares-2/ 2020-09-23T15:31:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-has-carried-out-a-directed-share-issue-of-2118640-shares-at-a-subscription-price-of-sek-236-per-share/ 2020-09-23T21:04:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-har-genomfort-en-riktad-nyemission-av-2-118-640-aktier-till-en-teckningskurs-om-236-kronor-per-aktie/ 2020-09-23T21:04:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusions-teckningsoptionsprogram-2020-2022/ 2020-09-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusions-warrant-program-2020-2022/ 2020-09-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/okat-antal-aktier-och-roster-i-xvivo-perfusion-ab-publ-5/ 2020-09-30T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/increased-number-of-shares-and-votes-in-xvivo-perfusion-ab-publ-5/ 2020-09-30T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/valberedning-i-xvivo-perfusion-ab-publ-4/ 2020-09-30T06:45:00+00:00 https://xvivo.considbrs.se/pressreleases/nomination-committee-of-xvivo-perfusion-ab-publ-4/ 2020-09-30T06:45:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v/ 2020-10-01T16:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v/ 2020-10-01T16:00:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-extra-bolagsstamma-i-xvivo-perfusion/ 2020-10-14T14:30:00+00:00 https://xvivo.considbrs.se/pressreleases/report-from-extraordinary-general-meeting-in-xvivo-perfusion/ 2020-10-14T14:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-10/ 2020-10-16T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-10/ 2020-10-16T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/first-in-the-world-with-products-for-all-major-solid-organs/ 2020-10-23T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/forst-i-varlden-med-produkter-inom-samtliga-stora-organomraden/ 2020-10-23T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/publication-in-the-lancet-shows-better-survival-of-transplanted-kidneys-after-cold-machine-perfusion-with-oxygen/ 2020-11-20T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/the-lancet-publikation-visar-pa-battre-overlevnad-av-transplanterade-njurar-efter-kall-maskinperfusion-med-tillsatt-syrgas/ 2020-11-20T07:30:00+00:00 https://xvivo.considbrs.se/pressreleases/first-patient-in-the-european-heart-preservation-study-transplanted/ 2020-12-01T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/forsta-patienten-i-den-europeiska-hjartpreservationsstudien-har-blivit-transplanterad/ 2020-12-01T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-report-on-operations/ 2021-01-08T15:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-bokslutskommunike/ 2021-01-08T15:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-offentliggor-bokslutskommunike-2020/ 2021-01-28T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-presents-report-on-operations-2020/ 2021-01-28T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/publication-in-the-new-england-journal-of-medicine-shows-complications-after-liver-transplantation-significantly-reduced-with-cold-oxygenated-machine-perfusion/ 2021-02-26T15:30:00+00:00 https://xvivo.considbrs.se/pressreleases/publikation-i-the-new-england-journal-of-medicine-visar-pa-signifikant-minskning-av-komplikationer-efter-levertransplantation-med-syresatt-kall-maskinperfusion/ 2021-02-26T15:30:00+00:00 https://xvivo.considbrs.se/pressreleases/notice-to-attend-the-annual-general-meeting-in-xvivo-perfusion-ab-publ-3/ 2021-03-15T07:50:00+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-arsstamma-i-xvivo-perfusion-ab-publ-3/ 2021-03-15T07:50:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-report-2020/ 2021-03-29T10:35:00+00:00 https://xvivo.considbrs.se/pressreleases/arsredovisning-2020/ 2021-03-29T10:35:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-9/ 2021-04-08T05:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-9/ 2021-04-08T05:00:00+00:00 https://xvivo.considbrs.se/pressreleases/rattelse-telefonkonferens-avseende-delarsrapport/ 2021-04-08T06:22:00+00:00 https://xvivo.considbrs.se/pressreleases/australian-heart-preservation-study-underway/ 2021-04-19T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/forsta-patienten-transplanterad-i-australiensisk-hjartstudie/ 2021-04-19T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-march-2021/ 2021-04-21T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-mars-2021/ 2021-04-21T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/bulletin-from-annual-general-meeting-in-xvivo-perfusion-ab-publ-3/ 2021-04-22T14:12:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-arsstamma-i-xvivo-perfusion-ab-publ-3/ 2021-04-22T14:12:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-submits-510k-file-with-us-fda-for-kidney-assist-transport/ 2021-05-04T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/510k-ansokan-for-kidney-assist-transport-inlamnad-till-amerikanska-fda/ 2021-05-04T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/great-interest-for-xvivos-european-heart-study/ 2021-05-25T08:30:00+00:00 https://xvivo.considbrs.se/pressreleases/stort-intresse-for-xvivos-europeiska-hjartstudie/ 2021-05-25T08:30:00+00:00 https://xvivo.considbrs.se/pressreleases/the-national-institute-for-health-and-care-excellence-nice-gives-support-for-evlp/ 2021-05-28T12:08:00+00:00 https://xvivo.considbrs.se/pressreleases/national-institute-for-health-and-care-excellence-nice-i-storbritannien-ger-stod-for-evlp/ 2021-05-28T12:08:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-8/ 2021-06-28T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-8/ 2021-06-28T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/change-in-number-of-shares-and-votes-in-xvivo-perfusion-2/ 2021-06-30T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-2/ 2021-06-30T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-to-start-their-digital-transformation-journey-together-with-umc-groningen-to-enable-an-increase-in-successful-transplants/ 2021-07-08T13:45:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-startar-sin-digitala-transformationsresa-tillsammans-med-umc-groningen-for-att-mojliggora-en-okning-av-framgangsrika-transplantationer/ 2021-07-08T13:45:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-presents-interim-report-january-june-2021/ 2021-07-13T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-offentliggor-delarsrapport-januari-juni-2021/ 2021-07-13T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivos-kapitalmarknadsdag-2021/ 2021-08-23T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-capital-markets-day-2021/ 2021-08-23T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-presenterar-strategiska-fokusomraden-for-2022-2026-pa-kapitalmarknadsdagen/ 2021-09-23T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-capital-markets-day-presents-strategic-focus-areas-for-2022-2026/ 2021-09-23T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/language-correction-xvivo-capital-markets-day-presents-strategic-focus-areas-for-2022-2026/ 2021-09-23T07:13:00+00:00 https://xvivo.considbrs.se/pressreleases/nomination-committee-of-xvivo-perfusion-ab-publ-3/ 2021-09-30T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/valberedning-i-xvivo-perfusion-ab-publ-3/ 2021-09-30T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/advance-publication-of-interim-report-january-september-2021/ 2021-10-05T09:30:00+00:00 https://xvivo.considbrs.se/pressreleases/tidigarelaggning-av-delarsrapport-januari-september-2021/ 2021-10-05T09:30:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-7/ 2021-10-07T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-7/ 2021-10-07T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/record-for-a-donor-heart-outside-the-body-using-ground-breaking-xvivo-technology/ 2021-10-18T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/rekord-for-ett-donatorhjarta-utanfor-kroppen-med-banbrytande-teknologi-fran-xvivo/ 2021-10-18T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-presents-interim-report-januari-september-2021/ 2021-10-21T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-offentliggor-delarsrapport-januari-september-2021/ 2021-10-21T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-has-entered-into-an-agreement-to-acquire-the-us-organ-recovery-company-star-teams-and-finances-the-acquisition-through-a-private-placement-of-new-shares/ 2021-10-28T15:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-har-ingatt-avtal-om-att-forvarva-det-amerikanska-foretaget-for-organhamtning-star-teams-och-finansierar-forvarvet-genom-en-nyemission-av-aktier/ 2021-10-28T15:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-avser-att-genomfora-en-riktad-nyemission-av-aktier/ 2021-10-28T15:31:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-intends-to-carry-out-a-directed-issue-of-shares/ 2021-10-28T15:31:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-has-carried-out-a-directed-share-issue-of-746269-shares-at-a-subscription-price-of-sek-335-per-share/ 2021-10-28T19:58:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-har-genomfort-en-riktad-nyemission-av-746-269-aktier-till-en-teckningskurs-om-335-kronor-per-aktie/ 2021-10-28T19:58:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-completes-the-acquisition-of-star-teams-inc/ 2021-11-09T18:45:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-slutfor-forvarvet-av-star-teams-inc/ 2021-11-09T18:45:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-expands-its-management-team-by-appointing-jaya-tiwari-to-vice-president-clinical-and-regulatory-affairs-for-the-us/ 2021-11-22T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa/ 2021-11-22T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/increased-number-of-shares-and-votes-in-xvivo-perfusion-ab-publ-4/ 2021-11-30T07:00:00+00:00 https://xvivo.considbrs.se/pressreleases/okat-antal-aktier-och-roster-i-xvivo-perfusion-ab-publ-4/ 2021-11-30T07:00:00+00:00 https://xvivo.considbrs.se/pressreleases/in-line-with-xvivos-dedication-to-the-us-market-fredrik-dalborg-is-appointed-managing-director-north-america/ 2021-12-08T09:00:00+00:00 https://xvivo.considbrs.se/pressreleases/i-linje-med-xvivos-fokus-pa-den-amerikanska-marknaden-har-fredrik-dalborg-utsetts-till-managing-director-for-nordamerika/ 2021-12-08T09:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-accelerates-their-business-in-brazil-by-signing-a-partnership-contract-with-contatti-medical/ 2021-12-21T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-accelererar-sin-verksamhet-i-brasilien-genom-att-teckna-ett-partnerskapsavtal-med-contatti-medical/ 2021-12-21T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivos-innovative-preservation-technology-used-in-the-worlds-first-ever-successful-heart-xenotransplantation-pig-to-human/ 2022-01-10T21:34:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivos-innovativa-teknologi-for-bevarande-av-hjartan-har-anvants-i-varldens-forsta-framgangsrika-xenotransplantation-gris-till-manniska/ 2022-01-10T21:34:00+00:00 https://xvivo.considbrs.se/pressreleases/correction-xvivos-innovative-preservation-technology-used-in-the-worlds-first-ever-successful-heart-xenotransplantation-pig-to-human/ 2022-01-10T22:39:00+00:00 https://xvivo.considbrs.se/pressreleases/rattelse-xvivos-innovativa-teknologi-for-bevarande-av-hjartan-har-anvants-i-varldens-forsta-framgangsrika-xenotransplantation-gris-till-manniska/ 2022-01-10T22:39:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-report-on-operations-2021/ 2022-01-12T09:15:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-bokslutskommunike-2021/ 2022-01-12T09:15:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivos-kidney-assist-transport-receives-510k-clearance-by-us-fda-which-is-xvivos-first-regulatory-cleared-product-for-abdominal-transplantation-in-the-us/ 2022-01-21T21:50:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa/ 2022-01-21T21:50:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-presents-report-on-operations-2021/ 2022-01-27T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-avlamnar-bokslutskommunike-2021/ 2022-01-27T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-gains-regulatory-approval-in-china-for-perfadex-plus-the-global-gold-standard-for-lung-preservation/ 2022-02-02T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-far-viktigt-marknadsgodkannande-i-kina-for-perfadex-plus-den-globala-standardbehandlingen-for-bevarande-av-lungor/ 2022-02-02T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-obtains-its-first-certificate-under-eu-medical-device-regulation-mdr-for-kidney-assist-transport/ 2022-03-23T16:45:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-far-sitt-forsta-certifikat-enligt-eus-forordning-medical-device-regulation-mdr-for-kidney-assist-transport/ 2022-03-23T16:45:00+00:00 https://xvivo.considbrs.se/pressreleases/notice-to-attend-the-annual-general-meeting-in-xvivo-perfusion-ab-publ-2/ 2022-03-24T18:00:00+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-arsstamma-i-xvivo-perfusion-ab-publ-2/ 2022-03-24T18:00:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-report-2021/ 2022-04-04T15:20:00+00:00 https://xvivo.considbrs.se/pressreleases/arsredovisning-2021/ 2022-04-04T15:20:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-6/ 2022-04-13T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-6/ 2022-04-13T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-presents-interim-report-january-march-2022/ 2022-04-25T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-avlamnar-delarsrapport-januari-mars-2022/ 2022-04-25T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/bulletin-from-annual-general-meeting-in-xvivo-perfusion-ab-publ-2/ 2022-04-26T14:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-arsstamma-i-xvivo-perfusion-ab-publ-2/ 2022-04-26T14:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-submits-an-ide-application-to-us-fda-for-its-innovative-heart-technology-a-significant-milestone/ 2022-04-27T08:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-lamnar-in-en-ide-ansokan-till-amerikanska-fda-for-sin-innovativa-hjartteknologi-en-betydande-milstolpe/ 2022-04-27T08:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices/ 2022-05-04T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-har-tecknat-avtal-med-ledande-amerikanska-sjukhus-och-levererat-de-forsta-kidney-assist-transport/ 2022-05-04T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/reimbursement-established-for-lung-and-liver-transplant-in-the-netherlands-based-on-results-from-clinical-trials-with-xvivos-leading-technologies/ 2022-05-12T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/statlig-ersattning-for-lung-och-levertransplantation-i-nederlanderna-resultat-fran-kliniska-provningar-med-xvivos-ledande-teknologier-har-spelat-en-viktig-roll/ 2022-05-12T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-to-advance-their-digital-transformation-journey-in-partnership-with-the-world-leading-cleveland-clinic-to-increase-the-number-of-successful-lung-transplants/ 2022-05-18T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-tar-viktiga-steg-i-sin-digitala-transformationsresa-i-samarbete-med-varldsledande-cleveland-clinic-for-att-oka-antalet-framgangsrika-lungtransplantationer/ 2022-05-18T06:00:00+00:00 https://xvivo.considbrs.se/pressreleases/chu-toulouse-in-france-starts-liver-and-lung-perfusion-programs-using-xvivo-technologies/ 2022-05-19T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/chu-toulouse-i-frankrike-introducerar-program-for-maskinperfusion-for-lever-och-lunga-med-hjalp-av-xvivos-teknologier/ 2022-05-19T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-5/ 2022-06-29T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-5/ 2022-06-29T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/change-in-number-of-shares-and-votes-in-xvivo-perfusion/ 2022-06-30T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion/ 2022-06-30T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-presents-interim-report-january-june-2022/ 2022-07-13T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-avlamnar-delarsrapport-januari-juni-2022/ 2022-07-13T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-enters-into-an-agreement-to-acquire-its-italian-distributor-securing-a-unique-business-model/ 2022-08-01T14:15:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-ingar-avtal-om-att-forvarva-sin-italienska-distributor-sakrar-en-unik-affarsmodell/ 2022-08-01T14:15:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-capital-markets-day-2022/ 2022-08-24T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivos-kapitalmarknadsdag-2022/ 2022-08-24T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-har-erhallit-breakthrough-device-designation-fran-fda-for-sin-liver-assist/ 2022-09-20T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-granted-breakthrough-device-designation-from-the-fda-for-the-liver-assist-device/ 2022-09-20T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-presents-strategy-for-2023-2027-at-its-capital-markets-day/ 2022-09-21T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-presenterar-strategi-for-2023-2027-pa-kapitalmarknadsdagen/ 2022-09-21T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusions-ceo-dag-andersson-has-passed-away/ 2022-09-27T06:55:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusions-vd-dag-andersson-har-avlidit/ 2022-09-27T06:55:00+00:00 https://xvivo.considbrs.se/pressreleases/nomination-committee-of-xvivo-perfusion-ab-publ-2/ 2022-09-30T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/valberedning-i-xvivo-perfusion-ab-publ-2/ 2022-09-30T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-4/ 2022-10-21T09:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-4/ 2022-10-21T09:30:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-september-2022/ 2022-10-27T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-september-2022/ 2022-10-27T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/positive-results-presented-from-the-australian-new-zealand-heart-preservation-study/ 2022-11-24T14:50:00+00:00 https://xvivo.considbrs.se/pressreleases/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland/ 2022-11-24T14:50:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-strengthens-its-executive-management-team-by-appointing-lena-hagman-to-chief-operating-officer-coo/ 2022-11-28T14:15:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-starker-sin-ledningsgrupp-genom-att-utse-lena-hagman-till-chief-operating-officer-coo/ 2022-11-28T14:15:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-completes-the-acquisition-of-the-machine-and-perfusion-business-from-avionord-s-r-l/ 2022-11-30T10:10:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-slutfor-forvarvet-av-maskin-och-perfusionsverksamheten-fran-avionord-s-r-l/ 2022-11-30T10:10:00+00:00 https://xvivo.considbrs.se/pressreleases/christoffer-rosenblad-appointed-as-ceo-of-xvivo/ 2022-11-30T16:40:00+00:00 https://xvivo.considbrs.se/pressreleases/christoffer-rosenblad-utsedd-till-vd-i-xvivo/ 2022-11-30T16:40:00+00:00 https://xvivo.considbrs.se/pressreleases/increased-number-of-shares-and-votes-in-xvivo-perfusion-ab-publ-3/ 2022-12-30T09:00:00+00:00 https://xvivo.considbrs.se/pressreleases/okat-antal-aktier-och-roster-i-xvivo-perfusion-ab-publ-3/ 2022-12-30T09:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-presents-report-on-operations-2022/ 2023-01-16T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-bokslutskommunike-2022/ 2023-01-16T14:00:00+00:00 https://xvivo.considbrs.se/pressreleases/report-on-operations-2022/ 2023-01-26T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/bokslutskommunike-2022/ 2023-01-26T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/notice-to-attend-the-annual-general-meeting-in-xvivo-perfusion-ab-publ/ 2023-03-23T16:40:00+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-arsstamma-i-xvivo-perfusion-ab-publ/ 2023-03-23T16:40:00+00:00 https://xvivo.considbrs.se/pressreleases/annual-report-2022/ 2023-04-03T20:20:00+00:00 https://xvivo.considbrs.se/pressreleases/arsredovisning-2022/ 2023-04-03T20:20:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-3/ 2023-04-17T07:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-3/ 2023-04-17T07:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-presents-interim-report-january-march-2023/ 2023-04-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-avlamnar-delarsrapport-januari-mars-2023/ 2023-04-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/bulletin-from-annual-general-meeting-in-xvivo-perfusion-ab-publ/ 2023-04-25T14:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-arsstamma-i-xvivo-perfusion-ab-publ/ 2023-04-25T14:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-publ-carries-out-new-issue-of-shares-through-set-off-of-claims/ 2023-05-11T19:55:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-ab-publ-genomfor-nyemission-av-aktier-genom-kvittning-av-fordringar/ 2023-05-11T19:55:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivos-ide-application-for-its-innovative-heart-preservation-technology-has-been-approved-by-the-us-fda/ 2023-05-15T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivos-ide-ansokan-for-sin-innovativa-hjartpreservationsteknologi-har-godkants-av-amerikanska-fda/ 2023-05-15T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/patient-inclusion-completed-in-european-clinical-trial-with-xvivos-heart-preservation-technology/ 2023-05-23T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/inklusion-av-patienter-avslutad-i-xvivos-europeiska-kliniska-studie-for-hjartpreservation/ 2023-05-23T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/increased-number-of-shares-and-votes-in-xvivo-perfusion-ab-publ-2/ 2023-05-31T09:00:00+00:00 https://xvivo.considbrs.se/pressreleases/okat-antal-aktier-och-roster-i-xvivo-perfusion-ab-publ-2/ 2023-05-31T09:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-conducts-a-commercial-integration-of-star-teams-in-the-us-strengthening-the-service-offering/ 2023-06-21T16:33:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-starker-tjansteerbjudandet-i-usa-genom-en-kommersiell-integration-av-star-teams/ 2023-06-21T16:33:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-avser-att-genomfora-en-riktad-nyemission-av-aktier/ 2023-10-18T12:06:49+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-intends-to-carry-out-a-directed-share-issue/ 2023-10-18T12:06:49+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-har-genomfort-en-riktad-nyemission-av-1-600-000-aktier-till-en-teckningskurs-om-275-kronor-per-aktie-och-tillfors-en-bruttolikvid-om-440-miljoner-kronor/ 2023-10-18T12:06:49+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-has-carried-out-a-directed-share-issue-of-1600000-shares-at-a-subscription-price-of-sek-275-per-share-raising-gross-proceeds-of-sek-440-million/ 2023-10-18T12:06:49+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-2/ 2023-10-18T12:06:49+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-2/ 2023-10-18T12:06:49+00:00 https://xvivo.considbrs.se/pressreleases/nomination-committee-of-xvivo-perfusion-ab-publ/ 2023-10-18T12:06:49+00:00 https://xvivo.considbrs.se/pressreleases/valberedning-i-xvivo-perfusion-ab-publ/ 2023-10-18T12:06:49+00:00 https://xvivo.considbrs.se/pressreleases/okat-antal-aktier-och-roster-i-xvivo-perfusion-ab-publ/ 2023-10-18T12:06:49+00:00 https://xvivo.considbrs.se/pressreleases/increased-number-of-shares-and-votes-in-xvivo-perfusion-ab-publ/ 2023-10-18T12:06:49+00:00 https://xvivo.considbrs.se/pressreleases/amerikanska-fda-ger-xvivo-godkannande-att-inkludera-dcd-hjartan-i-sin-ide-kliniska-studie/ 2023-10-18T12:06:50+00:00 https://xvivo.considbrs.se/pressreleases/us-fda-grants-xvivo-approval-to-include-dcd-hearts-in-ide-clinical-trial/ 2023-10-18T12:06:50+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-presents-interim-report-january-june-2023/ 2023-10-18T12:06:50+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-avlamnar-delarsrapport-januari-juni-2023/ 2023-10-18T12:06:50+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-has-decided-to-close-the-primecc-study-for-further-patient-inclusions-strategic-opportunities-will-be-evaluated/ 2023-10-18T12:06:50+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-har-beslutat-att-avsluta-ytterligare-patientinkludering-i-studien-av-primecc-strategiska-mojligheter-skall-utvarderas/ 2023-10-18T12:06:50+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-enters-into-a-strategic-collaboration-with-mtj-aviation-to-strengthen-organ-procurement-services-in-the-us/ 2023-10-18T12:06:50+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-inleder-ett-strategiskt-samarbete-med-mtj-aviation-for-att-starka-sin-tjanst-for-organhamtning-i-usa/ 2023-10-18T12:06:50+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport/ 2023-10-18T12:06:50+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report/ 2023-10-18T12:06:50+00:00 https://xvivo.considbrs.se/pressreleases/leading-acacemic-medical-center-performs-first-heart-transplant-in-the-u-s-utilizing-nihp-technology-as-part-of-xvivos-preserve-clinical-trial/ 2023-10-23T18:15:00+00:00 https://xvivo.considbrs.se/pressreleases/den-forsta-hjarttransplantationen-i-usa-med-hjalp-av-nihp-teknologin-inom-xvivos-kliniska-studie-preserve-har-utforts-av-ett-ledande-amerikanskt-universitetssjukhus/ 2023-10-23T18:15:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-september-2023/ 2023-10-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-september-2023/ 2023-10-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/resultat-publicerat-fran-en-studie-som-anvant-xvivos-hjartteknologi-i-australien-nya-zeeland/ 2023-11-03T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/results-from-a-australian-new-zealand-study-using-xvivos-heart-technology-published/ 2023-11-03T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-meddelar-en-nedskrivning-relaterad-till-primecc-om-17-msek-vilket-ej-paverkar-kassaflode-eller-ebitda/ 2023-12-14T16:32:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-announces-a-write-down-related-to-primecc-of-sek-17-million-not-affecting-cashflow-or-ebitda/ 2023-12-14T16:32:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-reaches-milestone-in-italy-1200-lifesaving-perfusions-performed-with-liver-assist/ 2023-12-22T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-nar-milstolpe-i-italien-1-200-livraddande-organperfusioner-utforda-med-liver-assist/ 2023-12-22T08:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-bokslutskommunike-2023/ 2024-01-12T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-report-on-operations-2023/ 2024-01-12T13:00:00+00:00 https://xvivo.considbrs.se/pressreleases/langtidsperfusion-av-lever-kan-effektivisera-planering-och-logistik-mojliggor-att-fler-levertransplantationer-genomfors-dagtid/ 2024-04-05T07:02:10+00:00 https://xvivo.considbrs.se/pressreleases/extended-perfusion-time-of-livers-can-streamline-planning-and-logistics-enabling-more-liver-transplants-to-be-performed-during-daytime/ 2024-04-05T07:02:10+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-presents-report-on-operations-2023/ 2024-04-08T13:09:07+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-avlamnar-bokslutskommunike-2023/ 2024-04-08T13:09:07+00:00 https://xvivo.considbrs.se/pressreleases/results-from-xvivos-clinical-trial-nihp2019-for-heart-preservation-presented-at-ishlt-in-prague/ 2024-04-11T08:45:14+00:00 https://xvivo.considbrs.se/pressreleases/arsredovisning-2023/ 2024-04-11T13:14:25+00:00 https://xvivo.considbrs.se/pressreleases/annual-report-2023/ 2024-04-11T13:14:25+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-28/ 2024-04-11T13:14:25+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-31/ 2024-04-11T13:14:25+00:00 https://xvivo.considbrs.se/pressreleases/resultat-presenterade-fran-xvivos-kliniska-studie-for-hjartpreservation-nihp2019-pa-ishlt-i-prag/ 2024-04-11T13:14:25+00:00 https://xvivo.considbrs.se/pressreleases/kallelse-till-arsstamma-i-xvivo-perfusion-ab-publ-12/ 2024-04-11T13:14:26+00:00 https://xvivo.considbrs.se/pressreleases/notice-to-attend-the-annual-general-meeting-in-xvivo-perfusion-ab-publ-4/ 2024-04-11T13:14:26+00:00 https://xvivo.considbrs.se/pressreleases/for-forsta-gangen-har-ett-donerat-hjarta-transporterats-over-atlanten-infor-transplantation-mojliggjordes-med-xvivos-hjartteknologi/ 2024-04-11T13:14:26+00:00 https://xvivo.considbrs.se/pressreleases/the-first-ever-transplantation-with-a-donor-heart-transported-across-the-atlantic-ocean-made-possible-by-the-use-of-xvivos-heart-technology/ 2024-04-11T13:14:26+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-mars-2024/ 2024-04-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-march-2024/ 2024-04-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/kommunike-fran-arsstamma-i-xvivo-perfusion-ab-publ-12/ 2024-04-25T13:40:00+00:00 https://xvivo.considbrs.se/pressreleases/bulletin-from-annual-general-meeting-in-xvivo-perfusion-ab-publ-4/ 2024-04-25T13:40:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-29/ 2024-06-25T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-juni-2024/ 2024-07-12T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-june-2024/ 2024-07-12T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/results-from-european-randomized-controlled-study-using-xvivos-heart-technology-published-in-the-lancet/ 2024-08-16T12:29:00+00:00 https://xvivo.considbrs.se/pressreleases/valberedning-i-xvivo-perfusion-ab-publ-12/ 2024-09-06T07:15:00+00:00 https://xvivo.considbrs.se/pressreleases/nomination-committee-of-xvivo-perfusion-ab-publ-8/ 2024-09-06T07:15:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-to-acquire-a-unique-communication-platform-for-the-transplant-process/ 2024-09-19T13:35:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-forvarvar-en-unik-kommunikationsplattform-for-transplantationsprocessen/ 2024-09-19T13:35:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-32/ 2024-09-27T06:57:25+00:00 https://xvivo.considbrs.se/pressreleases/resultaten-fran-den-europeiska-randomiserade-kontrollerade-studien-med-anvandning-av-xvivos-hjartteknologi-publicerade-i-the-lancet/ 2024-09-27T06:58:48+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-interim-report-30/ 2024-10-10T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-delarsrapport-33/ 2024-10-10T12:00:00+00:00 https://xvivo.considbrs.se/pressreleases/interim-report-january-september-2024/ 2024-10-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/delarsrapport-januari-september-2024/ 2024-10-24T05:30:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-utser-lena-hagman-till-vice-verkstallande-direktor/ 2024-11-14T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/xvivo-perfusion-appoints-lena-hagman-as-deputy-ceo/ 2024-11-14T15:00:00+00:00 https://xvivo.considbrs.se/pressreleases/inklusion-av-patienter-fardigstalld-fem-manader-tidigare-an-planerat-i-xvivos-amerikanska-kliniska-studie-for-hjartpreservation/ 2024-11-25T21:55:00+00:00 https://xvivo.considbrs.se/pressreleases/enrollment-completed-five-months-early-in-the-us-clinical-trial-evaluating-xvivos-heart-preservation-technology/ 2024-11-25T21:55:00+00:00 https://xvivo.considbrs.se/pressreleases/conference-call-on-year-end-report-2024/ 2025-01-13T13:30:00+00:00 https://xvivo.considbrs.se/pressreleases/telefonkonferens-avseende-bokslutskommunike-2024/ 2025-01-13T13:30:00+00:00 https://xvivo.considbrs.se/pressreleases/bokslutskommunike-2024/ 2025-01-28T06:30:00+00:00 https://xvivo.considbrs.se/pressreleases/year-end-report-2024/ 2025-01-28T06:30:00+00:00